Previous studies also reported that the PPARγ agonist ciglitazone promotes the TGFβ-dependent conversion of naïve effector T cells into Tregs, whereas PPARγ deficiency increases the infiltration of Th17 cells into the central nervous system in experimental autoimmune encephalomyelitis. Here, TGFB1 is linked to experimental autoimmune encephalomyelitis.